A phase II trial comparing dalpiciclib in combination with letrozole versus standard chemotherapy as neoadjuvant therapy in patients with high-risk HR- positive HER-2 negative breast cancer: DARLING-02
Zhang, Lina, Geng, Cuizhi, Liu, Yueping, Han, Jianjun, Han, Meng, Huang, Ruixue, Li, Xianqiao, Luo, Ruizhen, Li, Yuntao, Ma, Jie, Qi, Huaihua, Wang, Zunyi, Wang, Xiaochun, Yang, Chao, Yang, Jingqiang, Yang, Lixian, Yu, Jingjing, Zhang, Yingzhou, Zhang, Zhisheng, Zhou, Xinping
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Portable liquid adding device for individual soldier
LUN YANG, TAI JIANHUA, LI JIANGXIN, SU ZHIJIE, LIU JIE, LIU CHANG, QI HUAIHUA, MA QIANG
Year of Publication 13.09.2022
Get full text
Year of Publication 13.09.2022
Patent